close
References
  1. Trasolini NA, McKnight BM, Dorr LD. The opioid crisis and the orthopedic surgeon. J Arthroplasty. 2018;33(11):3379-3382.e1.
  2. Guo EW, Yedulla NR, Cross AG, et al. Older, male orthopaedic surgeons from southern geographies prescribe higher doses of post-operative narcotics than do their counterparts: a Medicare population study. Arthrosc Sports Med Rehabil. 2021;3(6):E1577-E1583.
  3. Volkow ND, McLellan TA, Cotto JH, Karithanom M, Weiss SRB. Characteristics of opioid prescriptions in 2009. JAMA. 2011;305(13):1299-1301.
  4. Runner RP, Luu AN, Thielen ZP, et al. Opioid use after discharge following primary unilateral total hip arthroplasty: how much are we overprescribing? J Arthroplasty. 2020;35(6S):S226-S230.
  5. Sabatino MJ, Kunkel ST, Ramkumar DB, Keeney BJ, Jevsevar DS. Excess opioid medication and variation in prescribing patterns following common orthopaedic procedures. J Bone Joint Surg Am. 2018;100(3):180-188.
  6. Hannon CP, Calkins TE, Li J, et al. The James A. Rand Young Investigator's Award: large opioid prescriptions are unnecessary after total joint arthroplasty: a randomized controlled trial. J Arthroplasty. 2019;34(7S):S4-S10.
  7. Delaney LD, Gunaseelan V, Rieck H, Dupree JM 4th, Hallstrom BR, Waljee JF. High-risk prescribing increases rates of new persistent opioid use in total hip arthroplasty patients. J Arthroplasty. 2020;35(9):2472-2479.e2.
  8. Brat GA, Agniel D, Beam A, et al. Postsurgical prescriptions for opioid naïve patients and association with overdose and misuse: retrospective cohort study. BMJ. 2018;360:j5790.
  9. S, Shrian-Chang K, Silva S, Goode V, Horn M, Cary MP Jr. Preoperative and postoperative opioid prescription rates in the total hip replacement surgical patient. Orthop Nurs. 2021;40(6):366-374.
  10. Hannon CP, Keating TC, Lange JK, Ricciardi BF, Waddell BS, Della Valle CJ. Anesthesia and analgesia practices in total joint arthroplasty: a survey of the American Association of Hip and Knee Surgeons Membership. J Arthroplasty. 2019;34(12):2872-2877.e2.
  11. Lipof JS, Thirukumaran CP, Greenstein AS, Zmich Z, Lander A, Ricciardi BF. Postdischarge opiate-prescribing habits for primary THA and TKA: a survey of American Association of Hip and Knee Surgeons members. Orthopedics. 2019;42(6):361-367.
  12. Hannon CP, Fillingham YA, Nam D, et al; AAHKS Anesthesia & Analgesia Clinical Practice Guideline Workgroup. Opioids in total joint arthroplasty: The Clinical Practice Guidelines of the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society. J Arthroplasty. 2020;35(10):2709-2714.
  13. Chalmers BP, Lebowitz J, Chiu YF, et al. Changes in opioid discharge prescriptions after primary total hip and total knee arthroplasty affect opioid refill rates and morphine milligram equivalents: an institutional experience of 20,000 patients. Bone Joint J. 2021;103-B(7 Supple B):103-110.
  14. Vaz KM, Huang PS, Copp SN. Standardized opioid prescription protocol reduces opioid consumption after total joint arthroplasty. J Am Acad Orthop Surg Glob Res Rev. 2019;3(12):e19.00163.
  15. Holte AJ, Carender CN, Noiseux NO, Otero JE, Brown TS. Restrictive opioid prescribing protocols following total hip arthroplasty and total knee arthroplasty are safe and effective. J Arthroplasty. 2019;34(7S):S135-S139.
  16. Reid DBC, Shapiro B, Shah KN, et al. Has a prescription-limiting law in Rhode Island helped to reduce opioid use after total joint arthroplasty? Clin Orthop Relat Res. 2020;478(2):205-215.
  17. Whale CS, Henningsen JD, Huff S, Schneider AD, Hijji FY, Froehle AW. Effects of the Ohio Opioid Prescribing Guidelines on total joint arthroplasty postsurgical prescribing and refilling behavior of surgeons and patients. J Arthroplasty. 2020;35(9):2397-2404.
  18. Cunningham DJ, Ryan SP, George SZ, Lewis BD. Opioid legislation and narcotic filling in total hip arthroplasty: descriptive study of time and state-level trends in the United States. Subst Abuse Treat Prev Policy. 2021;16(1):75.